Neovasc Inc. (NASDAQ:NVCN) moved up 9.26% and closed its last trading session at $1.77. This Medical Sector stock currently has the Market Capitalization of 118.35 Million. The Average Volume for the stock is measured as 1 Million. The Stock has a 52-Week High of $4.4 and 52-Week Low of $0.37 following the dates, it touched its 52-Week High on Mar 24, 2016 and 52-Week Low on May 20, 2016. Currently, the Return on Assets value for the trailing twelve months is 0% with the Return on Equity and Return on Investment of 0% and 0% respectively. This firm currently has YTD (year to date) performance of 2.31 Percent which is awesome. The Short Ratio for the stock is 3.31.
Neovasc Inc. (NASDAQ:NVCN) Price to Earnings (P/E) ratio is 0. EPS or Earning per Share stands at $-1.96. The TTM operating margin is 0 percent.
Neovasc Inc. (NASDAQ:NVCN) reports its Earnings on Thu 23 Mar (In 4 Days). The estimated EPS for the current quarter is said to be $. Following Earnings result, share price were DOWN 4 times out of last 5 Qtrs. The stock has added about 205.2% since it reported its last earnings. The Closing price of Neovasc Inc. (NASDAQ:NVCN) at Last Earnings was $0.58 as compared to the previous closing price of $1.62. The Predicted Move on the 7th day after Neovasc Inc. (NASDAQ:NVCN) will release its earnings at about 10%.
By Looking at Earnings History, Out of 12 Quarters when the Earnings were reported, Neovasc Inc. (NASDAQ:NVCN) beats earnings by 8%, The Stock Missed Earnings 4 times and has met earnings 3 times.
We will discuss the past Quarters Earnings below:
Neovasc Inc. (NASDAQ:NVCN) reported its previous quarter on 11/14/2016 where it reported the Actual Earnings of $-0.44. The Closing price before the company posted its earnings was $0.58. The Stock declined on the very next day of earnings and maintained its stock price at $0.52 by showing a % change of -10.34 percent from its previous closing price. The Next Day Volume after Earnings was reported as 1.38 Million. On the 7th day After Earnings Report, the stock hit its share price as $0.5 by showing -13.79% decrease from the Stock price Before Earnings were reported.
On 08/09/2016, the stock reported the EPS of $-1.25 where Analysts were projecting the EPS to be $-0.13 showing a difference of $-1.12. Thus Surprise Factor was there with -861.5 percent. Before Earnings Announcement on 08/09/2016, the firm had its stock price of $0.75. And immediately on the next day after earnings announcement, the stock declined -22.67% and closed its trading session at $0.58. On 7th Day after earnings release, Neovasc Inc. (NASDAQ:NVCN) dropped to -18.67% from $0.75 to $0.61.
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular products worldwide. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch biological tissue products that are used as components in third-party medical products, such as transcatheter heart valves for industry partners and other customers. In addition, it offers a line of collagen-based surgical patch products for use in cardiac reconstruction and vascular repair procedures, as well as other surgeries. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.